{"indexed":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T10:40:08Z","timestamp":1568284808188},"reference-count":47,"publisher":"Elsevier BV","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.metabol.2016.08.001","type":"article-journal","created":{"date-parts":[[2016,8,10]],"date-time":"2016-08-10T00:50:01Z","timestamp":1470790201000},"page":"64-68","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":"Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-\u03b3 agonists","prefix":"10.1016","volume":"66","author":[{"ORCID":"http:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Elisabetta","family":"Bugianesi","sequence":"additional","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[]}],"member":"78","container-title":"Metabolism","original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516300890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049516300890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T10:24:33Z","timestamp":1568283873000},"score":1.0,"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":47,"alternative-id":["S0026049516300890"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.metabol.2016.08.001","relation":{},"ISSN":["0026-0495"],"subject":["Endocrinology, Diabetes and Metabolism","Endocrinology"],"container-title-short":"Metabolism","assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-\u03b3 agonists","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2016.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}